MXPA03001985A - Cristales novedosos de n-hidroxi-2 (s) -metil-5 -etoximetoxi-4 (s)-[n -(4-fenoxifenilcarbonil) amino] pentamida, proceso para su produccion y composiciones farmaceuticas que los contienen. - Google Patents

Cristales novedosos de n-hidroxi-2 (s) -metil-5 -etoximetoxi-4 (s)-[n -(4-fenoxifenilcarbonil) amino] pentamida, proceso para su produccion y composiciones farmaceuticas que los contienen.

Info

Publication number: MXPA03001985A
Authority: MX; Mexico
Prior art keywords: etoximetoxi; phenoxyphenylcarbonyl; novedous; pentamide; metil
Prior art date: 2000-09-08

Application number

MXPA03001985A

Other languages

English (en)

Inventor

Shigehiro Okuyama

Original Assignee

Ono Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-08

Filing date

2001-09-07

Publication date

2003-09-05

2001-09-07 Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co

2003-09-05 Publication of MXPA03001985A publication Critical patent/MXPA03001985A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/50—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Reproductive Health (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Transplantation (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Vascular Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MXPA03001985A 2000-09-08 2001-09-07 Cristales novedosos de n-hidroxi-2 (s) -metil-5 -etoximetoxi-4 (s)-[n -(4-fenoxifenilcarbonil) amino] pentamida, proceso para su produccion y composiciones farmaceuticas que los contienen. MXPA03001985A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2000273445		2000-09-08
PCT/JP2001/007775 WO2002020467A1 (fr)	2000-09-08	2001-09-07	Nouveaux cristaux de n-hydroxy-2(s)-methyl-5-ethoxymethoxy-4(s)-[n-(4-phenoxyphenylcarbonyl)amino]pentanamide, leur procede de production et medicaments contenant ces cristaux en tant que substance active

Publications (1)

Publication Number	Publication Date
MXPA03001985A true MXPA03001985A (es)	2003-09-05

Family

ID=18759384

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03001985A MXPA03001985A (es)	2000-09-08	2001-09-07	Cristales novedosos de n-hidroxi-2 (s) -metil-5 -etoximetoxi-4 (s)-[n -(4-fenoxifenilcarbonil) amino] pentamida, proceso para su produccion y composiciones farmaceuticas que los contienen.

Country Status (16)

Country	Link
US (1)	US20040152785A1 (es)
EP (1)	EP1316547A4 (es)
KR (1)	KR20030059125A (es)
CN (1)	CN1473148A (es)
AU (1)	AU2001284477A1 (es)
BR (1)	BR0113760A (es)
CA (1)	CA2419744A1 (es)
CZ (1)	CZ2003636A3 (es)
HU (1)	HUP0302928A3 (es)
IL (1)	IL154625A0 (es)
MX (1)	MXPA03001985A (es)
NO (1)	NO20031030L (es)
PL (1)	PL361702A1 (es)
RU (1)	RU2003106391A (es)
WO (1)	WO2002020467A1 (es)
ZA (1)	ZA200301869B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0100761D0 (en)	2001-01-11	2001-02-21	Biocompatibles Ltd	Drug delivery from stents
NZ546011A (en) *	2003-10-21	2009-09-25	Warner Lambert Co	Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
US7713541B1 (en) *	2006-11-21	2010-05-11	Abbott Cardiovascular Systems Inc.	Zwitterionic terpolymers, method of making and use on medical devices

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6420427B1 (en) *	1997-10-09	2002-07-16	Ono Pharmaceutical Co., Ltd.	Aminobutyric acid derivatives

2001
- 2001-09-07 KR KR10-2003-7003266A patent/KR20030059125A/ko not_active Withdrawn
- 2001-09-07 US US10/362,290 patent/US20040152785A1/en not_active Abandoned
- 2001-09-07 PL PL01361702A patent/PL361702A1/xx unknown
- 2001-09-07 WO PCT/JP2001/007775 patent/WO2002020467A1/ja not_active Ceased
- 2001-09-07 EP EP01963509A patent/EP1316547A4/en not_active Withdrawn
- 2001-09-07 CN CNA018185525A patent/CN1473148A/zh active Pending
- 2001-09-07 CA CA002419744A patent/CA2419744A1/en not_active Abandoned
- 2001-09-07 AU AU2001284477A patent/AU2001284477A1/en not_active Abandoned
- 2001-09-07 MX MXPA03001985A patent/MXPA03001985A/es not_active Application Discontinuation
- 2001-09-07 HU HU0302928A patent/HUP0302928A3/hu unknown
- 2001-09-07 RU RU2003106391/04A patent/RU2003106391A/ru not_active Application Discontinuation
- 2001-09-07 BR BR0113760-3A patent/BR0113760A/pt not_active Application Discontinuation
- 2001-09-07 IL IL15462501A patent/IL154625A0/xx unknown
- 2001-09-07 CZ CZ2003636A patent/CZ2003636A3/cs unknown
2003
- 2003-03-05 NO NO20031030A patent/NO20031030L/no not_active Application Discontinuation
- 2003-03-06 ZA ZA200301869A patent/ZA200301869B/en unknown

Also Published As

Publication number	Publication date
IL154625A0 (en)	2003-09-17
AU2001284477A1 (en)	2002-03-22
CA2419744A1 (en)	2003-02-26
CZ2003636A3 (cs)	2003-08-13
PL361702A1 (en)	2004-10-04
US20040152785A1 (en)	2004-08-05
BR0113760A (pt)	2003-07-15
EP1316547A1 (en)	2003-06-04
ZA200301869B (en)	2004-06-25
EP1316547A4 (en)	2005-10-12
HUP0302928A3 (en)	2005-03-29
NO20031030L (no)	2003-05-08
HUP0302928A2 (hu)	2003-12-29
KR20030059125A (ko)	2003-07-07
NO20031030D0 (no)	2003-03-05
WO2002020467A1 (fr)	2002-03-14
RU2003106391A (ru)	2004-07-27
CN1473148A (zh)	2004-02-04

Similar Documents

Publication	Publication Date	Title
EE05198B1 (et)	2009-08-17	Asendatud aminometlrhma sisaldavad N-(arlsulfonl)beetaaminohappe derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsi£onid
NO20011478L (no)	2001-03-22	Nye N-(iminometyl)aminderivater, fremgangsmåte for fremstilling derav, anvendelse som medikamenter og sammensetningerinneholdende dem
HUP0200572A3 (en)	2004-07-28	Amine derivatives as protease inhibitors process for their preparation, pharmaceutical compositions containing them and their use
ECSP045220A (es)	2004-09-28	Derivados de n-fenil-2-pirimidin-amina
MX9100990A (es)	1992-05-04	Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
EE200300369A (et)	2003-10-15	Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
EE200300370A (et)	2003-10-15	Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
HUP0101176A3 (en)	2002-06-28	Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases, process for their preparation and pharmaceutical compositions containing them
DK1448195T3 (da)	2007-02-12	N-adamantylmethylderivater og mellemprodukter som farmaceutiske præparater og fremgangsmåde til fremstilling deraf
DK1294689T3 (da)	2006-08-28	Ny beta-krystallinsk form af t-butylaminsaltet af perindopril, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
ECSP055701A (es)	2005-05-30	Nuevos derivados de pirimidinamida y el uso de los mismos
PT1414816E (pt)	2005-04-29	Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
DK1322158T3 (da)	2012-11-19	Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
UY27410A1 (es)	2003-03-31	Formas novedosas crudas cristalinas
NO20025015D0 (no)	2002-10-18	Et pyridin-1-oksidderivat, og fremgangsmåte for dets overföring til farmasöytisk effektive forbindelser
BRPI0312413A2 (pt)	2016-08-02	compostos, composições farmacêuticas contendo os mesmos, e método de utilização para os mesmos
HUP0302723A3 (en)	2007-09-28	Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases, process for their preparation and pharmaceutical compositions containing them
DK1098891T3 (da)	2005-12-12	Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler
EE200400022A (et)	2004-04-15	Pürrolidiinoksadiasooli ja -tiadiasooli derivaadid, nende valmistamise meetod ja neid sisaldavad ravimkoostised
DK1118610T3 (da)	2002-12-16	Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
DK1525188T3 (da)	2008-11-17	Hidtil ukendte derivater af 4,4-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der indeholder dem
MXPA03001985A (es)	2003-09-05	Cristales novedosos de n-hidroxi-2 (s) -metil-5 -etoximetoxi-4 (s)-[n -(4-fenoxifenilcarbonil) amino] pentamida, proceso para su produccion y composiciones farmaceuticas que los contienen.
HUP0204430A3 (en)	2005-05-30	Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives, the obtained new compounds and pharmaceutical compositions containing thereof
PT1241169E (pt)	2003-11-28	Derivados de isoindoloindolona processo para a sua preparacao e as composicoes farmaceuticas que os contem
BR0008566B1 (pt)	2011-03-22	processo para cristalização de n-(4-trifluormetilfenil)-5-metil-isoxazol-4-carboxami da.

Legal Events

Date	Code	Title	Description
2013-08-31	FA	Abandonment or withdrawal